Chemours Co
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, … Read more
Chemours Co (CC) - Total Liabilities
Latest total liabilities as of September 2025: $7.27 Billion USD
Based on the latest financial reports, Chemours Co (CC) has total liabilities worth $7.27 Billion USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Chemours Co - Total Liabilities Trend (2012–2024)
This chart illustrates how Chemours Co's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Chemours Co Competitors by Total Liabilities
The table below lists competitors of Chemours Co ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Spyre Therapeutics Inc.
NASDAQ:SYRE
|
USA | $49.50 Million |
|
Sealand Securities Co Ltd
SHE:000750
|
China | CN¥51.53 Billion |
|
Garrett Motion Inc
NASDAQ:GTX
|
USA | $3.25 Billion |
|
Prestige Brand Holdings Inc
NYSE:PBH
|
USA | $1.67 Billion |
|
Guaranty Trust Holding Co. PLC GDR
LSE:GTCO
|
UK | $13.29 Trillion |
|
Dyne Therapeutics Inc
NASDAQ:DYN
|
USA | $214.83 Million |
|
Baytex Energy Corp
NYSE:BTE
|
USA | $955.59 Million |
|
Nichirei Corporation
PINK:NCHEY
|
USA | $261.73 Billion |
Liability Composition Analysis (2012–2024)
This chart breaks down Chemours Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.33 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 24.40 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.96 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Chemours Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Chemours Co (2012–2024)
The table below shows the annual total liabilities of Chemours Co from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $6.91 Billion | -8.01% |
| 2023-12-31 | $7.51 Billion | +14.99% |
| 2022-12-31 | $6.53 Billion | +1.00% |
| 2021-12-31 | $6.47 Billion | +3.21% |
| 2020-12-31 | $6.27 Billion | -4.51% |
| 2019-12-31 | $6.56 Billion | +3.48% |
| 2018-12-31 | $6.34 Billion | -1.34% |
| 2017-12-31 | $6.43 Billion | +7.92% |
| 2016-12-31 | $5.96 Billion | -3.44% |
| 2015-12-31 | $6.17 Billion | +167.59% |
| 2014-12-31 | $2.31 Billion | -1.58% |
| 2013-12-31 | $2.34 Billion | +12.16% |
| 2012-12-31 | $2.09 Billion | -- |